Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stuart Elborn

Showing results (11-20 of 290) with videos related to

Pageof 29
Sort By:
Lancet (London, England)|May 4, 2016
Cystic fibrosisJ Stuart Elborn
European Respiratory Review : an Official Journal of the European Respiratory Society|March 5, 2013
The impact of personalised therapies on respiratory medicineJ Stuart Elborn
Seminars in Respiratory and Critical Care Medicine|June 15, 2007
How can we prevent multisystem complications of cystic fibrosis?J Stuart Elborn
The Lancet. Respiratory Medicine|August 31, 2017
Clinical trial research in focus: ensuring new cystic fibrosis drugs fulfil their potentialJ Stuart Elborn, Jane Davies
American Journal of Respiratory and Critical Care Medicine|March 4, 2014
Bronchiectasis severity: time to scoreMarcos Restrepo, J Stuart Elborn
Advances in Therapy|January 27, 2015
Use of inhaled tobramycin in cystic fibrosisMichal Shteinberg, J Stuart Elborn
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 16, 2019
Using registries for research in CF. How can we be sure about the outputs?J Stuart Elborn, Tanja Gonska
Genome Medicine|December 21, 2010
Protein biomarkers in cystic fibrosis research: where next?Sally H Pattison, J Stuart Elborn
Expert Review of Respiratory Medicine|May 19, 2010
British thoracic society winter meeting 2008J Stuart Elborn, Terence E McManus
Expert Review of Respiratory Medicine|September 30, 2011
Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronic Pseudomonas aeruginosa infection in cystic fibrosisMichael D Parkins, J Stuart Elborn
Pageof 29

Showing results (11-20 of 290) with videos related to

Sort By:
Pageof 29
Lancet (London, England)|May 4, 2016
Cystic fibrosisJ Stuart Elborn
European Respiratory Review : an Official Journal of the European Respiratory Society|March 5, 2013
The impact of personalised therapies on respiratory medicineJ Stuart Elborn
Seminars in Respiratory and Critical Care Medicine|June 15, 2007
How can we prevent multisystem complications of cystic fibrosis?J Stuart Elborn
The Lancet. Respiratory Medicine|August 31, 2017
Clinical trial research in focus: ensuring new cystic fibrosis drugs fulfil their potentialJ Stuart Elborn, Jane Davies
American Journal of Respiratory and Critical Care Medicine|March 4, 2014
Bronchiectasis severity: time to scoreMarcos Restrepo, J Stuart Elborn
Advances in Therapy|January 27, 2015
Use of inhaled tobramycin in cystic fibrosisMichal Shteinberg, J Stuart Elborn
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 16, 2019
Using registries for research in CF. How can we be sure about the outputs?J Stuart Elborn, Tanja Gonska
Genome Medicine|December 21, 2010
Protein biomarkers in cystic fibrosis research: where next?Sally H Pattison, J Stuart Elborn
Expert Review of Respiratory Medicine|May 19, 2010
British thoracic society winter meeting 2008J Stuart Elborn, Terence E McManus
Expert Review of Respiratory Medicine|September 30, 2011
Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronic Pseudomonas aeruginosa infection in cystic fibrosisMichael D Parkins, J Stuart Elborn
Pageof 29